Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis

被引：47
作者：
Bauwens, Matthias [1 ]
De Saint-Hubert, Marijke
Devos, Ellen
Deckers, Niko [2 ]
Reutelingsperger, Chris [2 ]
Mortelmans, Luc
Himmelreich, Uwe [3 ]
Mottaghy, Felix M. [4 ]
Verbruggen, Alfons
机构：
[1] KULeuven, Lab Radiopharm, B-3000 Louvain, Belgium
[2] Maastricht Univ, Maastricht, Netherlands
[3] KULeuven, Biomed NMR Unit, MoSAIC, B-3000 Louvain, Belgium
[4] Rhein Westfal TH Aachen, Aachen, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2011年 / 38卷 / 03期
关键词：
Ga-68; Annexin A5; Apoptosis; Therapy evaluation; PET; DEATH IN-VIVO; CELL-DEATH; TUMOR RESPONSE; CHEMOTHERAPY; THERAPY; PROTEIN; GROWTH; F-18;
D O I：
10.1016/j.nucmedbio.2010.09.008
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Purpose: Two variants of Annexin A5 (Cys2-AnxA5 and Cys 165-AnxA5) were labelled with Gallium-68 in order to evaluate their biological properties. Procedures: Biodistribution and pharmacokinetics of the radiotracers were studied with mu PET in healthy mice and in a mouse model of hepatic apoptosis. mu PET imaging after IV injection of the tracers in combination with mu MRI was performed in Daudi tumor bearing mice before and after treatment with a combination of chemotherapy and radiotherapy. Results: The biodistribution data indicated a fast urinary clearance with only minor hepatobilliary clearance, although a high retention in the kidneys was observed. Animals treated with anti-Fas showed a 3 to 8 times higher liver uptake as compared to healthy animals. Tumor uptake of Ga-68-Cys2-AnxA5 and Ga-68-Cys165-AnxA5 was low but significantly increased after therapy. Conclusion: Both Ga-68-Cys2-AnxA5 and Ga-65-Cys165-AnxA5 show a clear binding to apoptotic cells and are promising tracers for rapid evaluation of cancer therapy. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码：381 / 392
页数：12
相关论文
共 32 条
[1]   Apoptosis may be an early event of progestin therapy for endometrial hyperplasia [J].
Amezcua, CA ;
Lu, JJ ;
Felix, JC ;
Stanczyk, FZ ;
Zheng, WX .
GYNECOLOGIC ONCOLOGY, 2000, 79 (02) :169-176
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   The Imaging of apoptosis with the radiolabeled annexin V: Optimal timing for clinical feasibility [J].
Belhocine, T ;
Steinmetz, N ;
Li, C ;
Green, A ;
Blankenberg, FG .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2004, 3 (01) :23-32
[4]  
Belhocine T, 2002, CLIN CANCER RES, V8, P2766
[5]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[6]   Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo [J].
De Saint-Hubert, Marijke ;
Mottaghy, Felix M. ;
Vunckx, Kathleen ;
Nuyts, Johan ;
Fonge, Humphrey ;
Prinsen, Kristof ;
Stroobants, Sigrid ;
Mortelmans, Luc ;
Deckers, Niko ;
Hofstra, Leo ;
Reutelingsperger, Chris P. M. ;
Verbruggen, Alfons ;
Rattat, Dirk .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (03) :1356-1363
[7]   Molecular imaging of cell death [J].
De Saint-Hubert, Marijke ;
Prinsen, Kristof ;
Mortelmans, Luc ;
Verbruggen, Alfons ;
Mottaghy, Felix M. .
METHODS, 2009, 48 (02) :178-187
[8]  
Fromigue O, 2000, J BONE MINER RES, V15, pS480
[9]   DISSEMINATED OR LOCALIZED GROWTH OF A HUMAN B-CELL TUMOR (DAUDI) IN SCID MICE [J].
GHETIE, MA ;
RICHARDSON, J ;
TUCKER, T ;
JONES, D ;
UHR, JW ;
VITETTA, ES .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :481-485
[10]   Production of [F-18]fluoroannexin for imaging apoptosis with PET [J].
Grierson, JR ;
Yagle, KJ ;
Eary, JF ;
Tait, JF ;
Gibson, DF ;
Lewellen, B ;
Link, JM ;
Krohn, KA .
BIOCONJUGATE CHEMISTRY, 2004, 15 (02) :373-379
1234